Abstract
It has been thought that incretin signaling prevents arteriosclerosis, and very recently anti-arteriosclerotic effects through GLP-1 receptor were finally demonstrated in clinical human study. The purpose of this study was to investigate how vascular GLP-1 receptor expression is influenced in human subjects. First, we evaluated GLP-1 receptor expression in human arteries in immunostaining. Next, we separated the artery into the intima and media, and evaluated gene expression levels of various factors. We divided the subjects into obesity and non-obesity group and compared their expression levels between them. Finally, we evaluated which factors determine vascular GLP-1 receptor expression. GLP-1 receptor expression in intima and media was lower in obesity group compared to non-obesity group which was correlated with the alteration of TCF7L2 expression. Multiple regression analyses showed that BMI was an independent determining factor for GLP-1 receptor expression in the intima and media. Furthermore, using small interfering RNA method and TCF7L2-EGFP adenovirus, we showed that TCF7L2 was involved in GLP-1 receptor expression in human vascular cells. Taken together, vascular GLP-1 receptor and TCF7L2 expression was significantly...Continue Reading
References
Mar 1, 1988·Circulation Research·A N OrekhovV N Smirnov
Sep 9, 2004·American Journal of Physiology. Endocrinology and Metabolism·Thomas NyströmAke Sjöholm
Mar 16, 2007·Diabetes·Gang XuSusan Bonner-Weir
Oct 12, 2007·Physiological Reviews·Jens Juul Holst
Mar 21, 2008·Trends in Molecular Medicine·Jens J HolstSten Madsbad
Apr 26, 2008·Diabetes, Obesity & Metabolism·Kasper AaboeJens Juul Holst
Sep 13, 2008·Molecular and Cellular Endocrinology·Jens Juul HolstCarolyn F Deacon
Jan 13, 2009·The Journal of Endocrinology·Hongbin LiuRichard W Simpson
Jan 27, 2009·Diabetes·Gabriela da Silva XavierGuy A Rutter
Apr 24, 2009·Human Molecular Genetics·Luan ShuKathrin Maedler
Jan 14, 2010·Diabetes·Masayuki ArakawaHirotaka Watada
Jan 11, 2011·Biochemical and Biophysical Research Communications·Hiromasa GotoHirotaka Watada
May 13, 2011·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Tracey GaspariAnthony E Dear
Jan 31, 2012·Atherosclerosis·Aya ShirakiKoichi Node
Sep 5, 2012·Nature Reviews. Endocrinology·Juris J Meier
Dec 12, 2012·European Journal of Pharmacology·Yoichiro HirataMasataka Sata
Jan 9, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J J Holst
Jan 29, 2014·Endocrinology·Charles PykeLotte Bjerre Knudsen
Oct 31, 2014·Human Molecular Genetics·Ryan K MitchellGabriela Da Silva Xavier
Mar 21, 2015·International Journal of Molecular Sciences·Hideaki Kaneto, Taka-aki Matsuoka
Oct 23, 2015·Cell Reports·Roshni SrivastavaArya Mani
Dec 3, 2015·Diabetes Care·Tomoya MitaUNKNOWN Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial
Jan 30, 2016·Diabetes Care·Tomoya MitaUNKNOWN Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial
Jun 14, 2016·The New England Journal of Medicine·Steven P MarsoUNKNOWN LEADER Trial Investigators
Citations
Nov 6, 2020·Journal of Diabetes Investigation·Tomohiko Kimura, Kohei Kaku
Dec 16, 2020·Endocrine Reviews·Brent A McLeanDaniel J Drucker
Nov 3, 2020·BMJ Open Diabetes Research & Care·Charles-Henri MalbertKaren L Jones
Dec 17, 2020·International Journal of Molecular Sciences·Hideaki KanetoKohei Kaku
Feb 23, 2021·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Zhensheng ZhangXiao Xu
Mar 9, 2021·EBioMedicine·Dandan MaoJuliana Chung Ngor Chan
Apr 4, 2021·International Journal of Molecular Sciences·Hideaki KanetoKohei Kaku
Apr 16, 2021·Journal of Diabetes Research·Kunimasa YagiKazuyuki Tobe
Aug 8, 2021·International Journal of Molecular Sciences·Hideaki KanetoKohei Kaku
Oct 7, 2021·Journal of Cellular Physiology·Laura Del Bosque-PlataClaudia Gragnoli